Results 181 to 190 of about 5,452,648 (239)
Frequency and Predictors of Small Intestinal Bacterial Overgrowth in Patients with Functional Dyspepsia. [PDF]
Euroasian J HepatogastroenterolChittem R +9 more
europepmc +1 more source
[What are dyspepsia, organic dyspepsia and functional dyspepsia?].
Acta gastroenterologica Latinoamericana, 2008 openaire +1 more source
Clinical Evidence Linking the Gut Microbiome and Functional Dyspepsia: A Systematic Review and Meta-Analysis. [PDF]
BiomedicinesLee K, Kim H, Wang JH.
europepmc +1 more source
Exploring Clinical Similarities and Distinctions Between Gastroparesis and Functional Dyspepsia: A Propensity-Matched Cohort Study. [PDF]
Neurogastroenterol MotilRao S +7 more
europepmc +1 more source
Simotang oral liquid alleviates functional dyspepsia-related motility dysfunction through Ca<sup>2+</sup>-dependent smooth muscle contraction and Nrf2/NF-κB modulation. [PDF]
J Food Drug AnalMao G, He C, Liu J, Wu D, Zeng P, Mao Y.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Functional Dyspepsia: Current Understanding and Future Perspective
Digestion, 2023Background: Functional dyspepsia (FD) is a common disorder characterized by chronic or recurrent upper abdominal pain or discomfort without any structural abnormalities in the gastrointestinal tract. FD is categorized into two subgroups based on symptoms:
Tadayuki Oshima
semanticscholar +1 more source
Alimentary Pharmacology and Therapeutics, 2023
Functional dyspepsia (FD) is one of the most frequent conditions in gastroenterological outpatient health care. Most recent research in FD has shifted its focus to duodenal pathophysiological mechanisms, although current treatments still focus mainly the
B. Broeders +8 more
semanticscholar +1 more source
Functional dyspepsia (FD) is one of the most frequent conditions in gastroenterological outpatient health care. Most recent research in FD has shifted its focus to duodenal pathophysiological mechanisms, although current treatments still focus mainly the
B. Broeders +8 more
semanticscholar +1 more source
The treatment of functional dyspepsia: present and future
Expert Review of Gastroenterology & Hepatology, 2023Introduction Functional dyspepsia (FD) is a prevalent, but frequently overlooked and/or under diagnosed disorder of gut-brain interaction (DGBI). Functional dyspepsia frequently co-exists with other DGBIs, and persistent symptoms have a significant ...
B. Lacy, R. C. Chase, D. Cangemi
semanticscholar +1 more source
Current Opinion in Gastroenterology, 2016
Functional dyspepsia affects 10% of the population. Emerging data are beginning to unravel the pathogenesis of this heterogeneous disorder, and new data on treatment are helping to guide evidence-based practice. In this review, the latest advances are summarized and discussed.The Rome IV criteria were published in 2016 and are similar to Rome III but ...
Talley, Nicholas J. +2 more
openaire +7 more sources
Functional dyspepsia affects 10% of the population. Emerging data are beginning to unravel the pathogenesis of this heterogeneous disorder, and new data on treatment are helping to guide evidence-based practice. In this review, the latest advances are summarized and discussed.The Rome IV criteria were published in 2016 and are similar to Rome III but ...
Talley, Nicholas J. +2 more
openaire +7 more sources
Journal of Gastroenterology and Hepatology, 2021
Prospective trials evaluating efficacy of specific diet restriction in functional dyspepsia (FD) are scarce. We aimed to assess efficacy of low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet in FD, compared with ...
O. Goyal +5 more
semanticscholar +1 more source
Prospective trials evaluating efficacy of specific diet restriction in functional dyspepsia (FD) are scarce. We aimed to assess efficacy of low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet in FD, compared with ...
O. Goyal +5 more
semanticscholar +1 more source